Free · No account

Create your own personal news briefing

A daily PDF of the news that moves your tickers — summaries and market impact, delivered an hour before the open.

Zacks Investment Research

14 Jul 2026, 22:51 UTC · 1h ago

Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know

NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims

4 claims · each scored for market impact

What matters in this story

1
Amgen's projected EPS for the upcoming quarter is $5.55, representing a 7.81% decrease compared to the same period last year. — A significant year-over-year decline in earnings per share typically pressures stock prices and suggests weakening profitability.
-0.40
2
Amgen currently trades at a Forward P/E ratio of 16.25, which is a discount compared to the industry average of 20.52. — A valuation discount relative to peers may attract value investors, potentially providing a price floor.
+0.30
3
Amgen is projected to generate revenue of $9.45 billion in the coming quarter, a 2.9% increase over the prior year. — Modest revenue growth provides some fundamental support, though it is overshadowed by the projected earnings drop.
+0.20
4